Israel Englander Theratechnologies Inc. Transaction History

Millennium Management LLC

  • $199 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023
SELL
$0.78 - $1.01 $30,293 - $39,226
-38,838 Reduced 73.09%
14,296 $12,000
Q1 2023

May 15, 2023
SELL
$0.72 - $1.12 $19,968 - $31,062
-27,734 Reduced 34.3%
53,134 $43,000
Q4 2022

Feb 14, 2023
BUY
$0.83 - $8.04 $58,266 - $564,407
70,200 Added 658.04%
80,868 $73,000
Q3 2022

Nov 14, 2022
BUY
$1.98 - $2.42 $21,122 - $25,816
10,668 New
10,668 $25,000

Others Institutions Holding THTX

# of Institutions
1
Shares Held
29.2K
Call Options Held
0
Put Options Held
0
View Full List

About Theratechnologies Inc.

THTX Quotes by TradingView
  • Ticker THTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 95,141,600
  • Market Cap $116M
  • Description
  • Theratechnologies Inc., a biopharmaceutical company, focuses on the development and commercialization of various therapies to address the unmet medical needs in the United States, Canada, and Europe. The company offers EGRIFTA and EGRIFTA SV, for the reduction of excess abdominal fat in human immunodeficiency virus (HIV)-infected patients with l...
More about THTX
Track Israel Englander's Portfolio

Track Israel Englander Portfolio

Follow Israel Englander (Millennium Management LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email